Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing–remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study:
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Erlangen
Friedrich-Alexander-Universität Erlangen-Nürnberg
2017
|
| Schlagworte: | |
| Online-Zugang: | Volltext Volltext Volltext |
| Beschreibung: | Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich |
| Beschreibung: | 1 Online-Ressource |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV046048017 | ||
| 003 | DE-604 | ||
| 005 | 20190724 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190715s2017 gw |||| o||u| ||||||eng d | ||
| 015 | |a 19,O07 |2 dnb | ||
| 016 | 7 | |a 1189425262 |2 DE-101 | |
| 024 | 7 | |a urn:nbn:de:bvb:29-opus4-112336 |2 urn | |
| 035 | |a (OCoLC)1111867275 | ||
| 035 | |a (DE-599)DNB1189425262 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 044 | |a gw |c XA-DE-BY | ||
| 049 | |a DE-29 | ||
| 084 | |a 610 |2 sdnb | ||
| 100 | 1 | |a Khan, Omar |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing–remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study |c Omar Khan, Peter Rieckmann, Alexey Boyko, Krzysztof Selmaj, Natalia Ashtamker, Mat D. Davis, Scott Kolodny, Robert Zivadinov |
| 264 | 1 | |a Erlangen |b Friedrich-Alexander-Universität Erlangen-Nürnberg |c 2017 | |
| 300 | |a 1 Online-Ressource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich | ||
| 583 | 1 | |a Archivierung/Langzeitarchivierung gewährleistet |5 DE-101 |2 pdager | |
| 653 | |a Glatiramer acetate | ||
| 653 | |a relapsing–remitting multiple sclerosis | ||
| 653 | |a annualized relapse rate | ||
| 653 | |a low-frequency regimen | ||
| 653 | |a safety | ||
| 700 | 1 | |a Rieckmann, Peter |e Verfasser |4 aut | |
| 700 | 1 | |a Boyko, Alexey |e Verfasser |4 aut | |
| 700 | 1 | |a Selmaj, Krzysztof |e Verfasser |4 aut | |
| 700 | 1 | |a Ashtamker, Natalia |e Verfasser |4 aut | |
| 700 | 1 | |a Davis, Mat D. |e Verfasser |4 aut | |
| 700 | 1 | |a Kolodny, Scott |e Verfasser |4 aut | |
| 700 | 1 | |a Zivadinov, Robert |e Verfasser |4 aut | |
| 787 | 0 | 8 | |i Sonderdruck aus |t Multiple Sclerosis Journal |g 23 (2017), Seite 818 - 829 |o 10.1177/1352458516664033 |
| 856 | 4 | 0 | |u https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-112336 |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://d-nb.info/1189425262/34 |x Langzeitarchivierung Nationalbibliothek |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://open.fau.de/handle/openfau/11233 |x Verlag |z kostenfrei |3 Volltext |
| 912 | |a ebook | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031429578 | ||
| 347 | |b PDF | ||
Datensatz im Suchindex
| _version_ | 1804180312498896896 |
|---|---|
| any_adam_object | |
| author | Khan, Omar Rieckmann, Peter Boyko, Alexey Selmaj, Krzysztof Ashtamker, Natalia Davis, Mat D. Kolodny, Scott Zivadinov, Robert |
| author_facet | Khan, Omar Rieckmann, Peter Boyko, Alexey Selmaj, Krzysztof Ashtamker, Natalia Davis, Mat D. Kolodny, Scott Zivadinov, Robert |
| author_role | aut aut aut aut aut aut aut aut |
| author_sort | Khan, Omar |
| author_variant | o k ok p r pr a b ab k s ks n a na m d d md mdd s k sk r z rz |
| building | Verbundindex |
| bvnumber | BV046048017 |
| collection | ebook |
| ctrlnum | (OCoLC)1111867275 (DE-599)DNB1189425262 |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02403nmm a2200541zc 4500</leader><controlfield tag="001">BV046048017</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20190724 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190715s2017 gw |||| o||u| ||||||eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">19,O07</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1189425262</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">urn:nbn:de:bvb:29-opus4-112336</subfield><subfield code="2">urn</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1111867275</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1189425262</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BY</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Khan, Omar</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing–remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study</subfield><subfield code="c">Omar Khan, Peter Rieckmann, Alexey Boyko, Krzysztof Selmaj, Natalia Ashtamker, Mat D. Davis, Scott Kolodny, Robert Zivadinov</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Erlangen</subfield><subfield code="b">Friedrich-Alexander-Universität Erlangen-Nürnberg</subfield><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich</subfield></datafield><datafield tag="583" ind1="1" ind2=" "><subfield code="a">Archivierung/Langzeitarchivierung gewährleistet</subfield><subfield code="5">DE-101</subfield><subfield code="2">pdager</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Glatiramer acetate</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">relapsing–remitting multiple sclerosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">annualized relapse rate</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">low-frequency regimen</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">safety</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rieckmann, Peter</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Boyko, Alexey</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Selmaj, Krzysztof</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ashtamker, Natalia</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Davis, Mat D.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kolodny, Scott</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zivadinov, Robert</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="787" ind1="0" ind2="8"><subfield code="i">Sonderdruck aus</subfield><subfield code="t">Multiple Sclerosis Journal</subfield><subfield code="g">23 (2017), Seite 818 - 829</subfield><subfield code="o">10.1177/1352458516664033</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-112336</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://d-nb.info/1189425262/34</subfield><subfield code="x">Langzeitarchivierung Nationalbibliothek</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://open.fau.de/handle/openfau/11233</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031429578</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="b">PDF</subfield></datafield></record></collection> |
| id | DE-604.BV046048017 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:33:46Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031429578 |
| oclc_num | 1111867275 |
| open_access_boolean | 1 |
| owner | DE-29 |
| owner_facet | DE-29 |
| physical | 1 Online-Ressource |
| psigel | ebook |
| publishDate | 2017 |
| publishDateSearch | 2017 |
| publishDateSort | 2017 |
| publisher | Friedrich-Alexander-Universität Erlangen-Nürnberg |
| record_format | marc |
| spelling | Khan, Omar Verfasser aut Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing–remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study Omar Khan, Peter Rieckmann, Alexey Boyko, Krzysztof Selmaj, Natalia Ashtamker, Mat D. Davis, Scott Kolodny, Robert Zivadinov Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg 2017 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich Archivierung/Langzeitarchivierung gewährleistet DE-101 pdager Glatiramer acetate relapsing–remitting multiple sclerosis annualized relapse rate low-frequency regimen safety Rieckmann, Peter Verfasser aut Boyko, Alexey Verfasser aut Selmaj, Krzysztof Verfasser aut Ashtamker, Natalia Verfasser aut Davis, Mat D. Verfasser aut Kolodny, Scott Verfasser aut Zivadinov, Robert Verfasser aut Sonderdruck aus Multiple Sclerosis Journal 23 (2017), Seite 818 - 829 10.1177/1352458516664033 https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-112336 Resolving-System kostenfrei Volltext http://d-nb.info/1189425262/34 Langzeitarchivierung Nationalbibliothek kostenfrei Volltext https://open.fau.de/handle/openfau/11233 Verlag kostenfrei Volltext |
| spellingShingle | Khan, Omar Rieckmann, Peter Boyko, Alexey Selmaj, Krzysztof Ashtamker, Natalia Davis, Mat D. Kolodny, Scott Zivadinov, Robert Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing–remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study |
| title | Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing–remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study |
| title_auth | Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing–remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study |
| title_exact_search | Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing–remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study |
| title_full | Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing–remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study Omar Khan, Peter Rieckmann, Alexey Boyko, Krzysztof Selmaj, Natalia Ashtamker, Mat D. Davis, Scott Kolodny, Robert Zivadinov |
| title_fullStr | Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing–remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study Omar Khan, Peter Rieckmann, Alexey Boyko, Krzysztof Selmaj, Natalia Ashtamker, Mat D. Davis, Scott Kolodny, Robert Zivadinov |
| title_full_unstemmed | Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing–remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study Omar Khan, Peter Rieckmann, Alexey Boyko, Krzysztof Selmaj, Natalia Ashtamker, Mat D. Davis, Scott Kolodny, Robert Zivadinov |
| title_short | Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing–remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study |
| title_sort | efficacy and safety of a three times weekly dosing regimen of glatiramer acetate in relapsing remitting multiple sclerosis patients 3 year results of the glatiramer acetate low frequency administration open label extension study |
| url | https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-112336 http://d-nb.info/1189425262/34 https://open.fau.de/handle/openfau/11233 |
| work_keys_str_mv | AT khanomar efficacyandsafetyofathreetimesweeklydosingregimenofglatirameracetateinrelapsingremittingmultiplesclerosispatients3yearresultsoftheglatirameracetatelowfrequencyadministrationopenlabelextensionstudy AT rieckmannpeter efficacyandsafetyofathreetimesweeklydosingregimenofglatirameracetateinrelapsingremittingmultiplesclerosispatients3yearresultsoftheglatirameracetatelowfrequencyadministrationopenlabelextensionstudy AT boykoalexey efficacyandsafetyofathreetimesweeklydosingregimenofglatirameracetateinrelapsingremittingmultiplesclerosispatients3yearresultsoftheglatirameracetatelowfrequencyadministrationopenlabelextensionstudy AT selmajkrzysztof efficacyandsafetyofathreetimesweeklydosingregimenofglatirameracetateinrelapsingremittingmultiplesclerosispatients3yearresultsoftheglatirameracetatelowfrequencyadministrationopenlabelextensionstudy AT ashtamkernatalia efficacyandsafetyofathreetimesweeklydosingregimenofglatirameracetateinrelapsingremittingmultiplesclerosispatients3yearresultsoftheglatirameracetatelowfrequencyadministrationopenlabelextensionstudy AT davismatd efficacyandsafetyofathreetimesweeklydosingregimenofglatirameracetateinrelapsingremittingmultiplesclerosispatients3yearresultsoftheglatirameracetatelowfrequencyadministrationopenlabelextensionstudy AT kolodnyscott efficacyandsafetyofathreetimesweeklydosingregimenofglatirameracetateinrelapsingremittingmultiplesclerosispatients3yearresultsoftheglatirameracetatelowfrequencyadministrationopenlabelextensionstudy AT zivadinovrobert efficacyandsafetyofathreetimesweeklydosingregimenofglatirameracetateinrelapsingremittingmultiplesclerosispatients3yearresultsoftheglatirameracetatelowfrequencyadministrationopenlabelextensionstudy |